The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Animal Antibacterial and Antibiotics Market Research Report 2025

Global Animal Antibacterial and Antibiotics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1431763

No of Pages : 97

Synopsis
Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens but also among bacteria of the endogenous microflora of animals. The extent to which antibiotic use in animals will contribute to the antibiotic resistance in humans is still under much debate.
The global Animal Antibacterial and Antibiotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
One of the recent trends spurring this market’s growth is the increasing collaborations between academic institutions and leading companies in the market to develop novel products for animal healthcare.
This report aims to provide a comprehensive presentation of the global market for Animal Antibacterial and Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Antibacterial and Antibiotics.
Report Scope
The Animal Antibacterial and Antibiotics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Antibacterial and Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Antibacterial and Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Merial
Elanco
Bayer HealthCare
Biogénesis Bagó
Boehringer Ingelheim Vetmedica
Ceva Santé Animale
Dechra Pharmaceuticals
ECO Animal Health
Huvepharma
Neogen
Norbrook
Orion
Phibro Animal Health
Vétoquinol
Virbac
Vitafor
Segment by Type
Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Cephalosporins
Segment by Application
Livestock
Pets
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Antibacterial and Antibiotics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tetracyclines
1.2.3 Penicillins
1.2.4 Sulfonamides
1.2.5 Macrolides
1.2.6 Aminoglycosides
1.2.7 Cephalosporins
1.3 Market by Application
1.3.1 Global Animal Antibacterial and Antibiotics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Livestock
1.3.3 Pets
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Antibacterial and Antibiotics Market Perspective (2019-2030)
2.2 Animal Antibacterial and Antibiotics Growth Trends by Region
2.2.1 Global Animal Antibacterial and Antibiotics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Antibacterial and Antibiotics Historic Market Size by Region (2019-2024)
2.2.3 Animal Antibacterial and Antibiotics Forecasted Market Size by Region (2025-2030)
2.3 Animal Antibacterial and Antibiotics Market Dynamics
2.3.1 Animal Antibacterial and Antibiotics Industry Trends
2.3.2 Animal Antibacterial and Antibiotics Market Drivers
2.3.3 Animal Antibacterial and Antibiotics Market Challenges
2.3.4 Animal Antibacterial and Antibiotics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Antibacterial and Antibiotics Players by Revenue
3.1.1 Global Top Animal Antibacterial and Antibiotics Players by Revenue (2019-2024)
3.1.2 Global Animal Antibacterial and Antibiotics Revenue Market Share by Players (2019-2024)
3.2 Global Animal Antibacterial and Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Antibacterial and Antibiotics Revenue
3.4 Global Animal Antibacterial and Antibiotics Market Concentration Ratio
3.4.1 Global Animal Antibacterial and Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Antibacterial and Antibiotics Revenue in 2023
3.5 Animal Antibacterial and Antibiotics Key Players Head office and Area Served
3.6 Key Players Animal Antibacterial and Antibiotics Product Solution and Service
3.7 Date of Enter into Animal Antibacterial and Antibiotics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Antibacterial and Antibiotics Breakdown Data by Type
4.1 Global Animal Antibacterial and Antibiotics Historic Market Size by Type (2019-2024)
4.2 Global Animal Antibacterial and Antibiotics Forecasted Market Size by Type (2025-2030)
5 Animal Antibacterial and Antibiotics Breakdown Data by Application
5.1 Global Animal Antibacterial and Antibiotics Historic Market Size by Application (2019-2024)
5.2 Global Animal Antibacterial and Antibiotics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Animal Antibacterial and Antibiotics Market Size (2019-2030)
6.2 North America Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Antibacterial and Antibiotics Market Size by Country (2019-2024)
6.4 North America Animal Antibacterial and Antibiotics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Antibacterial and Antibiotics Market Size (2019-2030)
7.2 Europe Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Antibacterial and Antibiotics Market Size by Country (2019-2024)
7.4 Europe Animal Antibacterial and Antibiotics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Antibacterial and Antibiotics Market Size (2019-2030)
8.2 Asia-Pacific Animal Antibacterial and Antibiotics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Antibacterial and Antibiotics Market Size by Region (2019-2024)
8.4 Asia-Pacific Animal Antibacterial and Antibiotics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Antibacterial and Antibiotics Market Size (2019-2030)
9.2 Latin America Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Antibacterial and Antibiotics Market Size by Country (2019-2024)
9.4 Latin America Animal Antibacterial and Antibiotics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Antibacterial and Antibiotics Market Size (2019-2030)
10.2 Middle East & Africa Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Antibacterial and Antibiotics Market Size by Country (2019-2024)
10.4 Middle East & Africa Animal Antibacterial and Antibiotics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Animal Antibacterial and Antibiotics Introduction
11.1.4 Zoetis Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Detail
11.2.2 Merck Animal Health Business Overview
11.2.3 Merck Animal Health Animal Antibacterial and Antibiotics Introduction
11.2.4 Merck Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.2.5 Merck Animal Health Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Animal Antibacterial and Antibiotics Introduction
11.3.4 Merial Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.3.5 Merial Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Animal Antibacterial and Antibiotics Introduction
11.4.4 Elanco Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Bayer HealthCare
11.5.1 Bayer HealthCare Company Detail
11.5.2 Bayer HealthCare Business Overview
11.5.3 Bayer HealthCare Animal Antibacterial and Antibiotics Introduction
11.5.4 Bayer HealthCare Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.5.5 Bayer HealthCare Recent Development
11.6 Biogénesis Bagó
11.6.1 Biogénesis Bagó Company Detail
11.6.2 Biogénesis Bagó Business Overview
11.6.3 Biogénesis Bagó Animal Antibacterial and Antibiotics Introduction
11.6.4 Biogénesis Bagó Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.6.5 Biogénesis Bagó Recent Development
11.7 Boehringer Ingelheim Vetmedica
11.7.1 Boehringer Ingelheim Vetmedica Company Detail
11.7.2 Boehringer Ingelheim Vetmedica Business Overview
11.7.3 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Introduction
11.7.4 Boehringer Ingelheim Vetmedica Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.7.5 Boehringer Ingelheim Vetmedica Recent Development
11.8 Ceva Santé Animale
11.8.1 Ceva Santé Animale Company Detail
11.8.2 Ceva Santé Animale Business Overview
11.8.3 Ceva Santé Animale Animal Antibacterial and Antibiotics Introduction
11.8.4 Ceva Santé Animale Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.8.5 Ceva Santé Animale Recent Development
11.9 Dechra Pharmaceuticals
11.9.1 Dechra Pharmaceuticals Company Detail
11.9.2 Dechra Pharmaceuticals Business Overview
11.9.3 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Introduction
11.9.4 Dechra Pharmaceuticals Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.9.5 Dechra Pharmaceuticals Recent Development
11.10 ECO Animal Health
11.10.1 ECO Animal Health Company Detail
11.10.2 ECO Animal Health Business Overview
11.10.3 ECO Animal Health Animal Antibacterial and Antibiotics Introduction
11.10.4 ECO Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.10.5 ECO Animal Health Recent Development
11.11 Huvepharma
11.11.1 Huvepharma Company Detail
11.11.2 Huvepharma Business Overview
11.11.3 Huvepharma Animal Antibacterial and Antibiotics Introduction
11.11.4 Huvepharma Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.11.5 Huvepharma Recent Development
11.12 Neogen
11.12.1 Neogen Company Detail
11.12.2 Neogen Business Overview
11.12.3 Neogen Animal Antibacterial and Antibiotics Introduction
11.12.4 Neogen Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.12.5 Neogen Recent Development
11.13 Norbrook
11.13.1 Norbrook Company Detail
11.13.2 Norbrook Business Overview
11.13.3 Norbrook Animal Antibacterial and Antibiotics Introduction
11.13.4 Norbrook Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.13.5 Norbrook Recent Development
11.14 Orion
11.14.1 Orion Company Detail
11.14.2 Orion Business Overview
11.14.3 Orion Animal Antibacterial and Antibiotics Introduction
11.14.4 Orion Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.14.5 Orion Recent Development
11.15 Phibro Animal Health
11.15.1 Phibro Animal Health Company Detail
11.15.2 Phibro Animal Health Business Overview
11.15.3 Phibro Animal Health Animal Antibacterial and Antibiotics Introduction
11.15.4 Phibro Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.15.5 Phibro Animal Health Recent Development
11.16 Vétoquinol
11.16.1 Vétoquinol Company Detail
11.16.2 Vétoquinol Business Overview
11.16.3 Vétoquinol Animal Antibacterial and Antibiotics Introduction
11.16.4 Vétoquinol Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.16.5 Vétoquinol Recent Development
11.17 Virbac
11.17.1 Virbac Company Detail
11.17.2 Virbac Business Overview
11.17.3 Virbac Animal Antibacterial and Antibiotics Introduction
11.17.4 Virbac Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.17.5 Virbac Recent Development
11.18 Vitafor
11.18.1 Vitafor Company Detail
11.18.2 Vitafor Business Overview
11.18.3 Vitafor Animal Antibacterial and Antibiotics Introduction
11.18.4 Vitafor Revenue in Animal Antibacterial and Antibiotics Business (2019-2024)
11.18.5 Vitafor Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’